Repligen Corp
NASDAQ:RGEN

Watchlist Manager

Repligen Corp

NASDAQ:RGEN

Watchlist

Dividends

Price: 142.58 USD 0.58% Market Closed

Market Cap: 8B USD

Have any thoughts about
Repligen Corp?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 142.58 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

RGEN Alert

Repligen Corp

142.58

+0.82 (+0.58%)

52 Week Range	119.79 208.42
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Repligen Corp

What unique competitive advantages
does Repligen Corp hold over its rivals?

What risks and challenges
does Repligen Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Repligen Corp.

What unique competitive advantages
does Repligen Corp hold over its rivals?

What risks and challenges
does Repligen Corp face in the near future?

Has there been any significant insider trading activity
in Repligen Corp recently?

Summarize the latest earnings call
of Repligen Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Repligen Corp.

Provide P/S
for Repligen Corp.

Provide P/E
for Repligen Corp.

Provide P/OCF
for Repligen Corp.

Provide P/FCFE
for Repligen Corp.

Provide P/B
for Repligen Corp.

Provide EV/S
for Repligen Corp.

Provide EV/GP
for Repligen Corp.

Provide EV/EBITDA
for Repligen Corp.

Provide EV/EBIT
for Repligen Corp.

Provide EV/OCF
for Repligen Corp.

Provide EV/FCFF
for Repligen Corp.

Provide EV/IC
for Repligen Corp.

Show me price targets
for Repligen Corp made by professional analysts.

What are the Revenue projections
for Repligen Corp?

How accurate were the past Revenue estimates
for Repligen Corp?

What are the Net Income projections
for Repligen Corp?

How accurate were the past Net Income estimates
for Repligen Corp?

What are the EPS projections
for Repligen Corp?

How accurate were the past EPS estimates
for Repligen Corp?

What are the EBIT projections
for Repligen Corp?

How accurate were the past EBIT estimates
for Repligen Corp?

Compare the revenue forecasts
for Repligen Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Repligen Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Repligen Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Repligen Corp compared to its peers.

Compare the P/E ratios
of Repligen Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Repligen Corp with its peers.

Analyze the financial leverage
of Repligen Corp compared to its main competitors.

Show all profitability ratios
for Repligen Corp.

Provide ROE
for Repligen Corp.

Provide ROA
for Repligen Corp.

Provide ROIC
for Repligen Corp.

Provide ROCE
for Repligen Corp.

Provide Gross Margin
for Repligen Corp.

Provide Operating Margin
for Repligen Corp.

Provide Net Margin
for Repligen Corp.

Provide FCF Margin
for Repligen Corp.

Show all solvency ratios
for Repligen Corp.

Provide D/E Ratio
for Repligen Corp.

Provide D/A Ratio
for Repligen Corp.

Provide Interest Coverage Ratio
for Repligen Corp.

Provide Altman Z-Score Ratio
for Repligen Corp.

Provide Quick Ratio
for Repligen Corp.

Provide Current Ratio
for Repligen Corp.

Provide Cash Ratio
for Repligen Corp.

What is the historical Revenue growth
over the last 5 years for Repligen Corp?

What is the historical Net Income growth
over the last 5 years for Repligen Corp?

What is the current Free Cash Flow
of Repligen Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Repligen Corp.

P/E
Price to Earnings

-4 255.5

Current

63.4

Median

32.2

Industry

Lower than median

Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

-4 255.5

Market Cap

8B USD

Net Income

-1.9m USD

All Countries

Forward Multiples

			Market Cap	P/E
US		Repligen Corp NASDAQ:RGEN	8B USD	-4 255.5
US	P	PerkinElmer Inc LSE:0KHE	1.3T USD	4 943.2
US		Thermo Fisher Scientific Inc NYSE:TMO	196.3B USD	32
US		Danaher Corp NYSE:DHR	170.3B USD	43.8
KR		Samsung Biologics Co Ltd KRX:207940	66.5T KRW	64.6
CH		Lonza Group AG SIX:LONN	37.6B CHF	65.6
US		Agilent Technologies Inc NYSE:A	38.5B USD	27.2
US		IQVIA Holdings Inc NYSE:IQV	36.7B USD	26.1
US		Mettler-Toledo International Inc NYSE:MTD	26.4B USD	33.2
US		West Pharmaceutical Services Inc NYSE:WST	23B USD	45.9
US		Illumina Inc NASDAQ:ILMN	22.3B USD	-14.1

				Earnings Growth
US		Repligen Corp NASDAQ:RGEN	Average P/E: 586.8 Negative Multiple: -4 255.5	218%
US	P	PerkinElmer Inc LSE:0KHE	4 943.2	4%
US		Thermo Fisher Scientific Inc NYSE:TMO	32	68%
US		Danaher Corp NYSE:DHR	43.8	44%
KR		Samsung Biologics Co Ltd KRX:207940	64.6	76%
CH		Lonza Group AG SIX:LONN	65.6	112%
US		Agilent Technologies Inc NYSE:A	27.2	46%
US		IQVIA Holdings Inc NYSE:IQV	26.1	82%
US		Mettler-Toledo International Inc NYSE:MTD	33.2	32%
US		West Pharmaceutical Services Inc NYSE:WST	45.9	9%
US		Illumina Inc NASDAQ:ILMN	Negative Multiple: -14.1	N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

97.5

2-Years Forward

P/E

78.5

3-Years Forward

P/E

60.2

Repligen Corp
NASDAQ:RGEN

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Repligen Corp NASDAQ:RGEN

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Repligen Corp
NASDAQ:RGEN

P/E
Price to Earnings